BRCA2 and cancer: Germline variations impacting cancer predisposition or disease progression are typically identified by targeted resequencing of genes of interest such as BRCA1 and BRCA2. As WGS/WES becomes more widely adopted, analysis of germline variation will move from single-gene approaches to analyses based on multiple cancer-associated genes, and the tested population will expand from at-risk individuals to the general population.